REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,390 | -6.6% | 33,900 | -16.9% | 0.02% | 0.0% |
Q2 2023 | $5,771 | -80.9% | 40,800 | -77.2% | 0.02% | -47.8% |
Q1 2023 | $30,150 | +117.4% | 179,094 | +118.7% | 0.05% | -27.0% |
Q4 2022 | $13,866 | -99.9% | 81,900 | -10.5% | 0.06% | -23.2% |
Q3 2022 | $17,120,000 | +23.9% | 91,500 | +7.5% | 0.08% | +32.3% |
Q2 2022 | $13,820,000 | -5.3% | 85,100 | +9.7% | 0.06% | +17.0% |
Q1 2022 | $14,595,000 | -16.5% | 77,600 | +17.6% | 0.05% | -13.1% |
Q4 2021 | $17,479,000 | +3.0% | 66,000 | +12.4% | 0.06% | -4.7% |
Q3 2021 | $16,963,000 | +18.9% | 58,700 | -17.9% | 0.06% | +25.5% |
Q2 2021 | $14,272,000 | -7.1% | 71,500 | -9.5% | 0.05% | -12.1% |
Q1 2021 | $15,362,000 | +0.6% | 79,020 | -0.9% | 0.06% | -1.7% |
Q4 2020 | $15,274,000 | +17.2% | 79,706 | -9.7% | 0.06% | +7.3% |
Q3 2020 | $13,028,000 | -5.9% | 88,305 | -21.2% | 0.06% | -9.8% |
Q2 2020 | $13,845,000 | +13.2% | 112,006 | -11.6% | 0.06% | -4.7% |
Q1 2020 | $12,231,000 | +578.4% | 126,700 | +549.7% | 0.06% | +700.0% |
Q4 2019 | $1,803,000 | -40.9% | 19,500 | -51.0% | 0.01% | +14.3% |
Q3 2019 | $3,052,000 | +86.9% | 39,800 | +109.5% | 0.01% | 0.0% |
Q2 2019 | $1,633,000 | +40.4% | 19,000 | -3.6% | 0.01% | +40.0% |
Q1 2019 | $1,163,000 | +12.0% | 19,700 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $1,038,000 | +23.3% | 19,700 | -29.4% | 0.01% | +25.0% |
Q3 2016 | $842,000 | -13.0% | 27,900 | -21.2% | 0.00% | 0.0% |
Q2 2016 | $968,000 | +11.8% | 35,400 | +9.6% | 0.00% | 0.0% |
Q1 2016 | $866,000 | +3.8% | 32,300 | +9.5% | 0.00% | 0.0% |
Q4 2015 | $834,000 | +11.3% | 29,500 | +9.7% | 0.00% | 0.0% |
Q3 2015 | $749,000 | -28.8% | 26,900 | +5.5% | 0.00% | -20.0% |
Q2 2015 | $1,052,000 | +12.9% | 25,500 | -16.9% | 0.01% | +25.0% |
Q1 2015 | $932,000 | +18.9% | 30,700 | -22.5% | 0.00% | +33.3% |
Q4 2014 | $784,000 | -51.0% | 39,600 | -50.7% | 0.00% | -25.0% |
Q3 2014 | $1,600,000 | +82.4% | 80,400 | +108.8% | 0.00% | 0.0% |
Q2 2014 | $877,000 | +19.5% | 38,500 | -32.6% | 0.00% | +33.3% |
Q1 2014 | $734,000 | -11.5% | 57,100 | -6.1% | 0.00% | -25.0% |
Q4 2013 | $829,000 | -2.9% | 60,800 | -21.0% | 0.00% | 0.0% |
Q3 2013 | $854,000 | +8.2% | 77,000 | -19.6% | 0.00% | +33.3% |
Q2 2013 | $789,000 | – | 95,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |